ESC 365 - MANIFEST-PF: multi-national survey on methods, efficacy and safety on the post-approval clinical use of pulsed field ablation

EHRA Premium Access

MANIFEST-PF: multi-national survey on methods, efficacy and safety on the post-approval clinical use of pulsed field ablation

Session: Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences

Topic: Rhythm Control, Catheter Ablation

Event: EHRA 2022

Congress Presentation

Add to my library

7 more presentations in this session

Sex differences in early rhythm control therapy in atrial fibrillation

Sex differences in early rhythm control therapy in atrial fibrillation - discussion.

MANIFEST-PF - discussion.

High radiofrequency power for faster and safer pulmonary vein ablation trial (POWER FAST III)

POWER FAST III - discussion.

Access the full session

Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources